COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis.
Moritz L SchmidbauerCaroline FerseFarid SalihCarsten M KlingnerRita MuslehStefan KunstMatthias WittstockBernhard NeumannKarl-Michael SchebeschJulian BöselJana GodauPiergiorgio LochnerElisabeth Hannah AdamKolja JahnkeBenjamin KnierIngo SchirotzekWolfgang MüllgesQuirin NotzMarkus DenglAndreas GüldnerOezguer A OnurJorge Garcia BorregaKonstantinos DimitriadisAlbrecht Günthernull On Behalf Of The Ignite Study GroupPublished in: Journal of clinical medicine (2022)
ICH in COVID-19 patients is rare, but it has a very poor prognosis. Different subtypes of ICH seen in COVID-19, support the assumption of heterogeneous and multifaceted pathomechanisms contributing to ICH in COVID-19. Further clinical and pathophysiological investigations are warranted to resolve the conflict between thromboembolic and hemorrhagic complications in the future.